Variability Among Cardiologists in the Management of Patients Under Secondary Prevention of Ischemic Heart Disease

Variability Among Cardiologists in the Management of Patients Under Secondary Prevention of Ischemic Heart Disease
Ricardo Stein, Caroline Alboim, Candice Campos, Renato Bandeira de Mello, Guido Aranha Rosito, Carisi Anne Polanczyk
disease, prevalence of previous myocardial infarction, and previous revascularization procedures showed no significant differences between the patients in groups I and II. In group I, 98% of the patients received aspirin, while, in group II, 83% of the patients received that drug (p=0.02). In regard to the use of lipid-lowering drugs, the prevalences were 60% in group I and 19% in group II (p=0.001). The lipid profile examination was
requested for 98% of group I individuals and 79% of group II individuals (p=0.003).
Conclusion
In regard to new medical evidence, mainly prescription of aspirin and lipid-lowering drugs, the management was more reliable in the outpatient clinic specifically aimed at treating ischemic heart disease.